Stockholders of SCM Microsystems approve increase of the amount of common shares

SCM Microsystems, Inc. (Nasdaq: SCMM) (Prime Standard: SMY), a leading provider of solutions for secure access, secure identity and secure exchange, announced today that its stockholders have approved an increase of the amount of common shares authorized during yesterday's annual meeting of stockholders.

At its annual meeting held on October 29, 2009, 61 percent of SCM's stockholders cast their votes and a majority followed the proposals of the Board of Directors to vote for all proposals. In addition to the election of directors, proposals included a 20 million share increase to the number of common shares authorized under the Company's Certificate of Incorporation, as well as a two million share increase in the number of shares reserved for issuance under the Company's 2007 Stock Option Plan.

Securing approval for these share increases enables SCM to continue to pursue mergers and acquisitions, which are an important component of the Company's growth strategy. SCM is focused on taking an active role in shaping the Identity Management and contactless markets through investments, consolidation with other providers and active promotion of the development of solutions that will enable these markets to grow.

"We are pleased that our stockholders have demonstrated their support for our growth strategy. The increase in our capital stock gives us more options in negotiating additional acquisitions and other transactions with attractive companies in our markets. With the increase of shares reserved for the 1997 Stock Option Plan, we can reward committee employees as well as recruit additional industry specialists for SCM," said Felix Marx, chief executive officer of SCM Microsystems. "We are grateful for the continued support of our stockholders and will continue to work to increase shareholder value."

SOURCE SCM Microsystems, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.